By Emily Field ( January 22, 2016, 8:20 PM EST) -- A Massachusetts federal judge on Friday nixed GlaxoSmithKline PLC's bid to dismiss all claims in multidistrict litigation alleging that the drug company's "off-label" promotion of its anti-nausea drug Zofran for morning sickness led to birth defects, saying that the bid seems to be premature at best....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.